Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Targeting glucose metabolism for cancer therapy.

Hamanaka RB, Chandel NS.

J Exp Med. 2012 Feb 13;209(2):211-5. doi: 10.1084/jem.20120162. Review.

2.

Metabolic reprogramming in cancer cells: glycolysis, glutaminolysis, and Bcl-2 proteins as novel therapeutic targets for cancer.

Li C, Zhang G, Zhao L, Ma Z, Chen H.

World J Surg Oncol. 2016 Jan 20;14(1):15. doi: 10.1186/s12957-016-0769-9. Review.

3.

Tumor aerobic glycolysis: new insights into therapeutic strategies with targeted delivery.

Talekar M, Boreddy SR, Singh A, Amiji M.

Expert Opin Biol Ther. 2014 Aug;14(8):1145-59. doi: 10.1517/14712598.2014.912270. Epub 2014 Apr 25. Review.

PMID:
24762115
4.

Metabolic reprogramming in cancer: unraveling the role of glutamine in tumorigenesis.

Daye D, Wellen KE.

Semin Cell Dev Biol. 2012 Jun;23(4):362-9. doi: 10.1016/j.semcdb.2012.02.002. Epub 2012 Feb 11. Review.

PMID:
22349059
5.

Reciprocal metabolic reprogramming through lactate shuttle coordinately influences tumor-stroma interplay.

Fiaschi T, Marini A, Giannoni E, Taddei ML, Gandellini P, De Donatis A, Lanciotti M, Serni S, Cirri P, Chiarugi P.

Cancer Res. 2012 Oct 1;72(19):5130-40. doi: 10.1158/0008-5472.CAN-12-1949. Epub 2012 Jul 31.

6.

Application of metabolic-control logic to fuel utilization and its significance in tumor cells.

Newsholme EA, Board M.

Adv Enzyme Regul. 1991;31:225-46. Review.

PMID:
1877389
7.

Metabolic phenotype of bladder cancer.

Massari F, Ciccarese C, Santoni M, Iacovelli R, Mazzucchelli R, Piva F, Scarpelli M, Berardi R, Tortora G, Lopez-Beltran A, Cheng L, Montironi R.

Cancer Treat Rev. 2016 Apr;45:46-57. doi: 10.1016/j.ctrv.2016.03.005. Epub 2016 Mar 8. Review.

PMID:
26975021
8.

Glucose metabolism and cancer.

Shaw RJ.

Curr Opin Cell Biol. 2006 Dec;18(6):598-608. Epub 2006 Oct 12. Review.

PMID:
17046224
9.

Metabolic changes during carcinogenesis: potential impact on invasiveness.

Smallbone K, Gatenby RA, Gillies RJ, Maini PK, Gavaghan DJ.

J Theor Biol. 2007 Feb 21;244(4):703-13. Epub 2006 Sep 16.

PMID:
17055536
10.

Pyruvate into lactate and back: from the Warburg effect to symbiotic energy fuel exchange in cancer cells.

Feron O.

Radiother Oncol. 2009 Sep;92(3):329-33. doi: 10.1016/j.radonc.2009.06.025. Epub 2009 Jul 13. Review.

PMID:
19604589
11.

Defining the molecular basis of tumor metabolism: a continuing challenge since Warburg's discovery.

de Souza AC, Justo GZ, de Araújo DR, Cavagis AD.

Cell Physiol Biochem. 2011;28(5):771-92. doi: 10.1159/000335792. Epub 2011 Dec 15. Review.

12.

PKM2 contributes to cancer metabolism.

Wong N, Ojo D, Yan J, Tang D.

Cancer Lett. 2015 Jan 28;356(2 Pt A):184-91. doi: 10.1016/j.canlet.2014.01.031. Epub 2014 Feb 4. Review.

PMID:
24508027
13.

The causes of cancer revisited: "mitochondrial malignancy" and ROS-induced oncogenic transformation - why mitochondria are targets for cancer therapy.

Ralph SJ, Rodríguez-Enríquez S, Neuzil J, Saavedra E, Moreno-Sánchez R.

Mol Aspects Med. 2010 Apr;31(2):145-70. doi: 10.1016/j.mam.2010.02.008. Epub 2010 Mar 2. Review.

PMID:
20206201
14.

Novel therapeutic targets of tumor metabolism.

Kishton RJ, Rathmell JC.

Cancer J. 2015 Mar-Apr;21(2):62-9. doi: 10.1097/PPO.0000000000000099. Review.

15.

Glucose Addiction in Cancer Therapy: Advances and Drawbacks.

Granja S, Pinheiro C, Reis RM, Martinho O, Baltazar F.

Curr Drug Metab. 2015;16(3):221-42. Review.

PMID:
26504932
16.

Glycolytic genes in cancer cells are more than glucose metabolic regulators.

Hu ZY, Xiao L, Bode AM, Dong Z, Cao Y.

J Mol Med (Berl). 2014 Aug;92(8):837-45. doi: 10.1007/s00109-014-1174-x. Epub 2014 Jun 8. Review. Erratum in: J Mol Med (Berl). 2014 Sep;92(9):1009.

PMID:
24906457
17.

Pyruvate kinase type M2: a key regulator of the metabolic budget system in tumor cells.

Mazurek S.

Int J Biochem Cell Biol. 2011 Jul;43(7):969-80. doi: 10.1016/j.biocel.2010.02.005. Epub 2010 Feb 13. Review.

PMID:
20156581
18.
19.
20.

Supplemental Content

Support Center